Armistice Capital, LLC
13F filer · CIK 0001601086Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$8.17BU.S. long equity reported on 13F
Positions322167 new · 93 closed
Net flow last quarter-$111MBuys minus sells
Top 10 positions weight12.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026322 positions | |||||
| $155M | 1.89% | 1.25% | +8.9% | Q3 2016 | |
| $123M | 1.51% | 4.55% | +39.6% | Q4 2019 | |
| $102M | 1.25% | 0.97% | +57.1% | Q1 2024 | |
| $102M | 1.25% | 0.45% | +37.0% | Q3 2017 | |
| $90.3M | 1.10% | 0.53% | -26.0% | Q1 2022 | |
| $89.3M | 1.09% | 1.67% | -67.9% | Q1 2021 | |
| $89.1M | 1.09% | 4.03% | -11.6% | Q3 2022 | |
| $87.4M | 1.07% | 1.29% | -48.4% | Q4 2018 | |
| $76.1M | 0.93% | 0.02% | +23.7% | Q3 2019 | |
| $74.5M | 0.91% | 2.59% | +15.3% | Q3 2015 | |
| $68.6M | 0.84% | 1.86% | -2.8% | Q2 2023 | |
| $67.8M | 0.83% | 0.00% | +8.6% | Q4 2017 | |
| $66.9M | 0.82% | 0.84% | -51.3% | Q3 2023 | |
| $65.4M | 0.80% | 9.04% | +30.6% | Q2 2020 | |
| $61.4M | 0.75% | 0.03% | +33.9% | Q1 2020 | |
| $58.7M | 0.72% | 8.43% | -7.3% | Q3 2023 | |
| $56.9M | 0.70% | 2.69% | -3.7% | Q4 2025 | |
| $56M | 0.69% | 0.10% | +148.6% | Q1 2017 | |
| $50.5M | 0.62% | 3.55% | +25.3% | Q2 2024 | |
| $46.8M | 0.57% | 1.96% | +47.6% | Q2 2025 | |
| $45.4M | 0.56% | 0.09% | +254.7% | Q2 2016 | |
| $45.3M | 0.55% | 2.77% | +20.2% | Q1 2022 | |
| $45.2M | 0.55% | 0.00% | +6.7% | Q3 2021 | |
| $42.7M | 0.52% | 4.07% | +33.7% | Q2 2018 | |
| $42M | 0.51% | 0.16% | +16.7% | Q3 2022 | |
| $40.3M | 0.49% | 4.13% | -1.6% | Q4 2022 | |
| $39M | 0.48% | 1.84% | +22.4% | Q3 2021 | |
| $35.9M | 0.44% | 0.02% | -4.0% | Q1 2020 | |
| $35.8M | 0.44% | 1.44% | -17.2% | Q3 2024 | |
| $33.6M | 0.41% | 1.20% | -14.2% | Q3 2024 | |
| $32.8M | 0.40% | Not reported | +4.4% | Q2 2025 | |
| $32.7M | 0.40% | 2.06% | -3.5% | Q4 2021 | |
| $32.5M | 0.40% | 0.36% | +38.5% | Q2 2022 | |
| $30.4M | 0.37% | 0.25% | +14.1% | Q4 2025 | |
| $30.1M | 0.37% | 0.00% | +64.9% | Q3 2020 | |
| $29.8M | 0.36% | 8.01% | +20.9% | Q4 2022 | |
| $28.8M | 0.35% | 0.06% | -48.7% | Q1 2024 | |
| $28.6M | 0.35% | 5.27% | +17.6% | Q4 2023 | |
| $28.1M | 0.34% | 0.08% | New | Q2 2026 | |
| $26.8M | 0.33% | 7.76% | +53.0% | Q3 2021 | |
| $26.6M | 0.33% | 3.62% | Not reported | Q3 2024 | |
| $25.4M | 0.31% | 1.07% | +346.4% | Q1 2025 | |
| $25.3M | 0.31% | 0.25% | +50.4% | Q3 2020 | |
| $25.3M | 0.31% | 9.81% | Not reported | Q4 2023 | |
| $24M | 0.29% | 5.64% | -5.1% | Q4 2022 | |
| $23.2M | 0.28% | 4.28% | +41.4% | Q2 2025 | |
| $23.1M | 0.28% | 7.87% | -16.7% | Q4 2021 | |
| $22.8M | 0.28% | 2.46% | -5.3% | Q4 2024 | |
| $22.6M | 0.28% | 0.37% | +40.4% | Q1 2022 | |
| $21.7M | 0.27% | Not reported | +55.7% | Q2 2023 | |
| Q1 2026Reported May 15, 2026248 positions | |||||
| $146M | 2.59% | 5.30% | +30.1% | Q1 2021 | |
| $141M | 2.51% | 2.50% | -26.0% | Q4 2018 | |
| $139M | 2.46% | 1.15% | -0.4% | Q3 2016 | |
| $98M | 1.74% | 3.27% | -31.4% | Q4 2019 | |
| $95.4M | 1.70% | 0.72% | -11.7% | Q1 2022 | |
| $91.9M | 1.63% | 4.58% | -10.5% | Q3 2022 | |
| $88.6M | 1.57% | 1.75% | -38.0% | Q3 2023 | |
| $64.5M | 1.15% | 2.22% | -15.6% | Q3 2015 | |
| $61.8M | 1.10% | 0.33% | -40.2% | Q3 2017 | |
| $57.6M | 1.02% | 1.92% | -2.3% | Q2 2023 | |
| $54.6M | 0.97% | 0.00% | -28.7% | Q4 2017 | |
| $52.7M | 0.94% | 9.13% | -6.2% | Q3 2023 | |
| $50.4M | 0.90% | 0.62% | -23.0% | Q1 2024 | |
| $45.5M | 0.81% | 2.81% | +224.8% | Q4 2025 | |
| $45M | 0.80% | 0.02% | +45.6% | Q1 2020 | |
| $41.6M | 0.74% | 2.84% | -3.0% | Q2 2024 | |
| $40M | 0.71% | 0.02% | Not reported | Q3 2019 | |
| $37.3M | 0.66% | 0.03% | +83.5% | Q1 2020 | |
| $35.8M | 0.64% | 2.34% | +8.2% | Q1 2022 | |
| $34.8M | 0.62% | 1.50% | -58.9% | Q3 2021 | |
| $34.6M | 0.62% | 6.93% | +53.1% | Q2 2020 | |
| $34.3M | 0.61% | 1.40% | +7.3% | Q3 2024 | |
| $34.1M | 0.61% | 0.00% | -39.7% | Q3 2021 | |
| $31.9M | 0.57% | 1.43% | +74.0% | Q2 2025 | |
| $31.4M | 0.56% | 0.25% | +89.1% | Q2 2022 | |
| $31M | 0.55% | 1.76% | Not reported | Q3 2024 | |
| $31M | 0.55% | 6.69% | +2.0% | Q4 2022 | |
| $30.4M | 0.54% | 4.21% | -24.3% | Q4 2022 | |
| AMAVNSAvanos Medical, Inc. | $28M | 0.50% | 4.29% | -37.5% | Q3 2020 |
| $27.9M | 0.50% | 0.04% | -57.0% | Q1 2017 | |
| $27.1M | 0.48% | 0.22% | +107.6% | Q4 2025 | |
| $26.3M | 0.47% | 0.13% | +118.3% | Q3 2022 | |
| $25.6M | 0.46% | 0.01% | -36.1% | Q4 2020 | |
| $25.1M | 0.45% | Not reported | +873.6% | Q4 2025 | |
| KPKALVKalVista Pharmaceuticals, Inc. | $24.9M | 0.44% | 2.41% | +54.5% | Q4 2025 |
| $24.6M | 0.44% | 0.27% | -14.7% | Q4 2021 | |
| $24.5M | 0.44% | 0.12% | +97.1% | Q1 2024 | |
| $24.4M | 0.43% | Not reported | -21.7% | Q3 2022 | |
| $24.3M | 0.43% | 5.23% | +29.9% | Q3 2021 | |
| $24.2M | 0.43% | 2.08% | -20.4% | Q4 2021 | |
| $24M | 0.43% | 0.01% | -14.8% | Q1 2022 | |
| $24M | 0.43% | Not reported | +8.0% | Q1 2024 | |
| $23.7M | 0.42% | 1.18% | -49.0% | Q4 2023 | |
| $23M | 0.41% | 3.25% | +22.5% | Q2 2018 | |
| $22.3M | 0.40% | Not reported | +19.8% | Q2 2025 | |
| $21.8M | 0.39% | 5.94% | -9.7% | Q4 2022 | |
| $21.3M | 0.38% | 4.52% | +9.9% | Q4 2023 | |
| $21M | 0.37% | 3.07% | +9.9% | Q2 2025 | |
| $20.7M | 0.37% | 0.00% | +22.5% | Q1 2023 | |
| $20.5M | 0.36% | 2.60% | -40.6% | Q4 2024 | |
| Q4 2025Reported Feb 17, 2026352 positions | |||||
| $213M | 2.53% | 3.44% | -14.5% | Q4 2018 | |
| $155M | 1.84% | 1.16% | +121.5% | Q3 2016 | |
| $146M | 1.74% | 2.83% | -1.5% | Q3 2023 | |
| $144M | 1.71% | 4.14% | -44.0% | Q1 2021 | |
| $137M | 1.63% | 4.81% | -2.5% | Q4 2019 | |
| $116M | 1.38% | 0.82% | +17.7% | Q1 2022 | |
| $108M | 1.29% | 0.55% | -5.9% | Q3 2017 | |
| $84.9M | 1.01% | 0.00% | +18.8% | Q4 2017 | |
| $83.4M | 0.99% | 3.66% | +27.2% | Q3 2021 | |
| $82.6M | 0.98% | 5.19% | +297.4% | Q3 2022 | |
| $79M | 0.94% | 2.65% | +5.0% | Q3 2015 | |
| $68.9M | 0.82% | 0.21% | Not reported | Q2 2023 | |
| $65M | 0.77% | 0.17% | -0.4% | Q3 2024 | |
| $64.8M | 0.77% | 0.09% | -32.9% | Q1 2017 | |
| $63.6M | 0.76% | 1.97% | +6.1% | Q2 2023 | |
| $63.1M | 0.75% | 0.81% | -17.1% | Q1 2024 | |
| $61.5M | 0.73% | 0.00% | -14.9% | Q3 2021 | |
| $57.2M | 0.68% | 0.00% | +35.6% | Q3 2020 | |
| $54M | 0.64% | 9.83% | -0.8% | Q3 2023 | |
| $51.3M | 0.61% | 5.62% | +5.7% | Q4 2022 | |
| $50M | 0.60% | 1.11% | +394.9% | Q4 2024 | |
| $49M | 0.58% | 0.02% | Not reported | Q4 2017 | |
| $48.8M | 0.58% | 0.09% | Not reported | Q2 2020 | |
| $46.8M | 0.56% | 0.00% | +104.6% | Q4 2020 | |
| $46.3M | 0.55% | 0.05% | +54.4% | Q2 2021 | |
| $45.7M | 0.54% | 2.32% | +47.2% | Q4 2023 | |
| $40.1M | 0.48% | 6.65% | +18.4% | Q4 2022 | |
| $40.1M | 0.48% | 2.59% | Not reported | Q4 2021 | |
| $39.7M | 0.47% | 1.32% | +14.5% | Q3 2024 | |
| $38.1M | 0.45% | 2.17% | +33.3% | Q1 2022 | |
| $36.4M | 0.43% | 0.02% | +14.2% | Q1 2020 | |
| $36.3M | 0.43% | Not reported | +118.0% | Q3 2022 | |
| AMAVNSAvanos Medical, Inc. | $35.9M | 0.43% | 6.89% | +28.0% | Q3 2020 |
| $35.8M | 0.43% | 4.57% | +15.5% | Q2 2020 | |
| $34.8M | 0.41% | 6.58% | +12.2% | Q4 2022 | |
| $34.6M | 0.41% | 0.02% | +49.0% | Q1 2022 | |
| $33.3M | 0.40% | 0.31% | +21.0% | Q4 2021 | |
| $33.1M | 0.39% | 1.02% | +22.0% | Q4 2024 | |
| $32.8M | 0.39% | 0.06% | +10.5% | Q2 2016 | |
| $32.2M | 0.38% | Not reported | +127.9% | Q2 2025 | |
| $30.6M | 0.36% | 1.98% | -22.0% | Q3 2024 | |
| $27.3M | 0.33% | 4.81% | -6.1% | Q4 2024 | |
| $27.3M | 0.32% | 4.55% | +68.7% | Q3 2021 | |
| $27.3M | 0.32% | 0.13% | +51.1% | Q2 2022 | |
| $26.1M | 0.31% | 0.02% | +2.3% | Q2 2020 | |
| $25.9M | 0.31% | Not reported | +23.8% | Q1 2024 | |
| $25.2M | 0.30% | 2.92% | +122.4% | Q2 2024 | |
| $25.1M | 0.30% | 0.02% | +399.0% | Q1 2019 | |
| $25M | 0.30% | Not reported | +13.4% | Q2 2023 | |
| $24.5M | 0.29% | 0.83% | +33.2% | Q2 2025 | |
| Q3 2025Reported Nov 17, 2025314 positions | |||||
| $201M | 2.98% | 4.10% | -30.8% | Q4 2018 | |
| $161M | 2.38% | 7.52% | -24.3% | Q1 2021 | |
| $136M | 2.01% | 4.97% | -41.1% | Q4 2019 | |
| $99M | 1.47% | 0.60% | -12.6% | Q3 2017 | |
| $97.8M | 1.45% | 0.70% | +3.1% | Q1 2022 | |
| $94.1M | 1.40% | 3.34% | +12.2% | Q3 2023 | |
| $72.8M | 1.08% | 2.88% | +1044.0% | Q3 2021 | |
| $70.4M | 1.04% | 0.13% | +25.2% | Q1 2017 | |
| $68M | 1.01% | 2.53% | +118.4% | Q3 2015 | |
| $67.9M | 1.01% | 0.00% | +41.0% | Q4 2017 | |
| $65.8M | 0.98% | 1.00% | -8.8% | Q1 2024 | |
| $59.7M | 0.89% | 0.17% | +5.1% | Q3 2024 | |
| $56.4M | 0.84% | 0.39% | +38.9% | Q3 2020 | |
| $56.1M | 0.83% | 0.00% | +21.2% | Q3 2021 | |
| $55M | 0.82% | 0.53% | -3.2% | Q3 2016 | |
| $48.4M | 0.72% | 2.56% | +8.9% | Q4 2021 | |
| $45.2M | 0.67% | 0.00% | +4.2% | Q3 2020 | |
| $42.8M | 0.63% | 0.10% | -27.5% | Q2 2020 | |
| $42.4M | 0.63% | 10.00% | +0.9% | Q4 2023 | |
| $41.3M | 0.61% | 5.37% | -24.7% | Q4 2022 | |
| $40.8M | 0.61% | Not reported | Not reported | Q4 2022 | |
| $40.5M | 0.60% | 1.44% | +48.8% | Q4 2023 | |
| $38.8M | 0.57% | 2.15% | +19.7% | Q2 2023 | |
| $34.9M | 0.52% | 0.14% | +8.6% | Q3 2022 | |
| $32.7M | 0.49% | 5.66% | -24.9% | Q4 2022 | |
| $30.7M | 0.45% | 1.31% | -34.6% | Q3 2022 | |
| $30.1M | 0.45% | 0.03% | Not reported | Q2 2021 | |
| $29.9M | 0.44% | 1.63% | +21.5% | Q1 2022 | |
| $29.3M | 0.43% | 0.03% | Not reported | Q4 2019 | |
| AMAVNSAvanos Medical, Inc. | $28.9M | 0.43% | 5.39% | +22.8% | Q3 2020 |
| $28.9M | 0.43% | 0.05% | Not reported | Q2 2016 | |
| $28.8M | 0.43% | 1.25% | Not reported | Q3 2024 | |
| $28.8M | 0.43% | 0.26% | +34.7% | Q4 2021 | |
| $27.9M | 0.41% | 0.00% | +169.0% | Q4 2020 | |
| $26.7M | 0.40% | 0.01% | +83.6% | Q1 2020 | |
| $25.4M | 0.38% | 5.86% | +30.0% | Q4 2022 | |
| $25.3M | 0.37% | 0.02% | +0.5% | Q2 2020 | |
| $23.9M | 0.36% | 0.09% | +72.0% | Q4 2024 | |
| $23M | 0.34% | 4.30% | +6.4% | Q1 2023 | |
| $22.3M | 0.33% | Not reported | -69.4% | Q1 2024 | |
| $22M | 0.33% | 0.02% | Not reported | Q4 2017 | |
| $21.4M | 0.32% | 2.60% | +8.0% | Q3 2024 | |
| $21.2M | 0.31% | 9.93% | Not reported | Q3 2023 | |
| $21.1M | 0.31% | 0.09% | +103.7% | Q2 2022 | |
| $20.5M | 0.30% | 4.04% | -54.8% | Q2 2020 | |
| $19.6M | 0.29% | 7.57% | -12.5% | Q2 2018 | |
| $19.6M | 0.29% | Not reported | -10.1% | Q3 2022 | |
| $19.4M | 0.29% | 0.13% | +78.6% | Q4 2020 | |
| $19.3M | 0.29% | 0.64% | +185.2% | Q2 2025 | |
| $18.5M | 0.27% | 3.14% | -1.9% | Q3 2021 | |
Premium opens every quarter this fund has filed